>> Download Survival Reports <<

>> Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial << (from: thelancet.com)

Published 2 weeks ago